RecruitingPhase 3

Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty

United States60 participantsStarted 2026-04-20

Plain-language summary

The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid

Who can participate

Age range18 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty Exclusion Criteria: * Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.

What they're measuring

VAS

Timeframe: 2 weeks

Trial details

NCT IDNCT06902714

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-07

Contact for this trial

Walter Smith

205-930-8554 waltersmith@uabmc.edu

View on ClinicalTrials.gov More Shoulder Arthroplasty trials